MICHAEL PARNELL: Open Payments
NPI 1750954327 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 9 payments from 8 companies in 2025. Trend: 2023 $640 · 2024 $735 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: FARXIGA, QULIPTA, FRUZAQLA, VRAYLAR, Veozah, NURTEC ODT, REPATHA, MOUNJARO.
Industry payments across AL — which companies pay providers there.
